Using MutPred derived mtDNA load scores to evaluate mtDNA variation in hypertension and diabetes in a two-population cohort: The SABPA study

Marianne Venter; Leone Malan; Etresia van Dyk; Joanna L. Elson; Francois H. van der Westhuizen

doi:10.1016/j.jgg.2016.12.003

Volume 44 Issue 3

Mar. 2017

Turn off MathJax

Article Contents

Article Navigation > Journal of Genetics and Genomics > 2017 > 44(3): 139-149

PDF( 1284 KB)

Using MutPred derived mtDNA load scores to evaluate mtDNA variation in hypertension and diabetes in a two-population cohort: The SABPA study

doi: 10.1016/j.jgg.2016.12.003

a
Human Metabolomics, North-West University, Potchefstroom 2531, South Africa
b
Hypertension in Africa Research Team (HART), North-West University, Potchefstroom 2531, South Africa
c
Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne NE1 3BZ, United Kingdom

More Information

Corresponding author: E-mail address: j.l.elson@ncl.ac.uk (Joanna L. Elson)
Received Date: 2016-08-24
Accepted Date: 2016-12-22
Rev Recd Date: 2016-12-11

Available Online: 2016-12-26

Publish Date: 2017-03-20

Abstract

Abstract

Mitochondrial DNA (mtDNA) variation has been implicated in many common complex diseases, but inconsistent and contradicting results are common. Here we introduce a novel mutational load hypothesis, which also considers the collective effect of mainly rare variants, utilising the MutPred Program. We apply this new methodology to investigate the possible role of mtDNA in two cardiovascular disease (CVD) phenotypes (hypertension and hyperglycaemia), within a two-population cohort (n = 363; mean age 45 ± 9 yrs). Very few studies have looked at African mtDNA variation in the context of complex disease, and none using complete sequence data in a well-phenotyped cohort. As such, our study will also extend our knowledge of African mtDNA variation, with complete sequences of Southern Africans being especially under-represented. The cohort showed prevalence rates for hypertension (58.6%) and prediabetes (44.8%). We could not identify a statistically significant role for mtDNA variation in association with hypertension or hyperglycaemia in our cohort. However, we are of the opinion that the method described will find wide application in the field, being especially useful for cohorts from multiple locations or with a variety of mtDNA lineages, where the traditional haplogroup association method has been particularly likely to generate spurious results in the context of association with common complex disease.
- Mitochondrial DNA,
- MutPred,
- Mutational load,
- Hypertension,
- Diabetes,
- African,
- SABPA

These authors contributed equally to this work.

FullText(HTML)

References(53)

References

[1]	Achilli, A., Olivieri, A., Pala, M. et al. Mitochondrial DNA backgrounds might modulate diabetes complications rather than T2DM as a whole PLoS One, 6 (2011),p. e21029
[2]	Ameh, J., Godwin, I., Obi, I. et al. The search for mitochondrial tRNALeu(UUR) A3243G mutation among type 2 diabetes mellitus patients in the Nigerian population Afr. J. Biotechnol., 10 (2011),pp. 13383-13389
[3]	American Diabetes Association Standards of medical care in diabetes Diabetes Care, 33 (2010),pp. S11-S61
[4]	Andrews, R.M., Kubacka, I., Chinnery, P.F. et al. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA Nat. Genet., 23 (1999),p. 147
[5]	Bandelt, H.-J., Forster, P., Röhl, A. Median-joining networks for inferring intraspecific phylogenies Mol. Biol. Evol., 16 (1999),pp. 37-48
[6]	Bandelt, H.-J., Forster, P., Sykes, B.C. et al. Mitochondrial portraits of human populations Genetics, 141 (1995),pp. 743-753
[7]	Cardena, M.M., Ribeiro-dos-Santos, A., Santos, S. et al. Amerindian genetic ancestry is associated with higher survival rates compared to African and European ancestry in Brazilian patients with heart failure Int. J. Cardiol., 176 (2014),pp. 527-528
[8]	Cardena, M.M., Ribeiro-Dos-Santos, A.K., Santos, S.E. et al. Mitochondrial and genomic ancestry are associated with etiology of heart failure in Brazilian patients J. Hum. Hypertens., 30 (2016),pp. 120-123
[9]	Cavadas, B., Soares, P., Camacho, R. et al. Fine time scaling of purifying selection on human nonsynonymous mtDNA mutations based on the worldwide population tree and mother-child pairs Hum. Mutat., 36 (2015),pp. 1100-1111
[10]	Chinnery, P.F., Elliott, H.R., Syed, A. et al. Mitochondrial DNA haplogroups and risk of transient ischaemic attack and ischaemic stroke: a genetic association study Lancet Neurol., 9 (2010),pp. 498-503
[11]	Elson, J.L., Andrews, R.M., Chinnery, P.F. et al. Analysis of European mtDNAs for recombination Am. J. Hum. Genet., 68 (2001),pp. 145-153
[12]	Elson, J.L., Herrnstadt, C., Preston, G. et al. Does the mitochondrial genome play a role in the etiology of Alzheimer's disease? Hum. Genet., 119 (2006),pp. 241-254
[13]	Elson, J.L., Turnbull, D.M., Howell, N. Comparative genomics and the evolution of human mitochondrial DNA: assessing the effects of selection Am. J. Hum. Genet., 74 (2004),pp. 229-238
[14]	Gorman, G.S., Schaefer, A.M., Ng, Y. et al. Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease Ann. Neurol., 77 (2015),pp. 753-759
[15]	Gurdasani, D., Carstensen, T., Tekola-Ayele, F. et al. The African genome variation project shapes medical genetics in Africa Nature, 517 (2015),pp. 327-332
[16]	Hamer, M., von Känel, R., Reimann, M. et al. Progression of cardiovascular risk factors in black Africans: 3 year follow up of the SABPA cohort study Atherosclerosis, 238 (2015),pp. 52-54
[17]	Hermida, R.C., Ayala, D.E., Mojon, A. et al. Differences between men and woman in ambulatory blood pressure thresholds for diagnosis of hypertension based on cardiovascular outcomes Chronobiol. Int., 30 (2013),pp. 221-232
[18]	Hernstadt, C., Elson, J.L., Fahy, E. et al. Reduced-median-network analysis of complete mitochondrial DNA coding-region sequences for the major African Asian, and European haplogroups Am. J. Hum. Genet., 70 (2002),pp. 1152-1171
[19]	Hernstadt, C., Howell, N. An evolutionary perspective on pathogenic mtDNA mutations: haplogroup associations of clinical disorders Mitochondrion, 4 (2004),pp. 791-798
[20]	Hollingsworth, K.G., Gorman, G.S., Trenell, M.I. et al. Cardiomyopathy is common in patients with the mitochondrial DNA m3243A>G mutation and correlates with mutation load Neuromuscul. Disord., 22 (2012),pp. 592-596
[21]	Kaufman, J.S., Dolman, L., Rushani, D. et al. The contribution of genomic research to explaining racial disparities in cardiovascular disease: a systematic review Am. J. Epidemiol., 181 (2015),pp. 464-472
[22]	Khogali, S.S., Myosi, B.M., Beattie, J.M. et al. A common mitochondrial DNA variant associated with susceptibility to dilated cardiomyopathy in two different populations Lancet, 357 (2001),pp. 1265-1267
[23]	Lammertyn, L., Schutte, A., Schutte, R. Blood glucose and nocturnal blood pressure in African and Caucasian men: the SABPA study Diabetes Res. Clin. Pract., 93 (2011),pp. 235-242
[24]	Li, B., Krishnan, V.G., Mort, M.E. et al. Automated inference of molecular mechanisms of disease from amino acid substitutions Bioinformatics, 25 (2009),pp. 2744-2750
[25]	Liu, C., Yang, Q., Hwang, S. et al. Association of genetic variation in the mitochondrial genome with blood pressure and metabolic traits Hypertension, 60 (2012),pp. 949-956
[26]	Mahmood, S.S., Levy, D., Vasan, R.S. et al. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective Lancet, 383 (2014),pp. 999-1008
[27]	Malan, L., Hamer, M., Frasure-Smith, N. et al. Cohort profile: sympathetic activity and ambulatory blood pressure in Africans (SABPA) prospective cohort study Int. J. Epidemiol., 44 (2015),pp. 1814-1822
[28]	Mancia, G., Fagard, R., Narkiewicz, K. et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC) J. Hypertens., 31 (2013),pp. 1281-1357
[29]	Manica, A., Amos, B., Balloux, F. et al. The effect of ancient population bottlenecks on human phenotypic variation Nature, 448 (2007),pp. 346-348
[30]	Mensah, G.A. Descriptive epidemiology of cardiovascular risk factors and diabetes in Africa Prog. Cardiovasc. Dis., 56 (2013),pp. 240-250
[31]	Moran, A., Forouzanfar, M., Sampsonc, U. et al. The epidemiology of cardiovascular diseases in Sub-Saharan Africa: the global burden of diseases, injuries and risk factors 2010 Study Prog. Cardiovasc. Dis., 56 (2013),pp. 234-239
[32]	Okin, P.M., Kjeldsen, S.E., Dahlöf, B. et al. Racial differences in incident heart failure during antihypertensive therapy Circ. Cardiovasc. Qual. Outcomes, 4 (2011),pp. 157-164
[33]	Owolabi, M.O., Mensah, G.A., Kimmel, P.A. et al. Understanding the rise in cardiovascular diseases in Africa: harmonising H3Africa genomic epidemiological teams and tools Cardiovasc. J. Afr., 25 (2014),pp. 134-136
[34]	Pereira, L., Soares, P., Radivoiac, P. et al. Comparing phylogeny and the predicted pathogenicity of protein variations reveals equal purifying selection across the global human mtDNA diversity Am. J. Hum. Genet., 88 (2011),pp. 433-439
[35]	Polzin, T., Daneschmand, S.V. On Steiner trees and minimum spanning trees in hypergraphs Oper. Res. Lett., 31 (2003),pp. 12-20
[36]	Robinson, M.T., Fischel-Ghodsian, N., Fraser, H.S. et al. Genetic influences on the increase in blood pressure with age in normotensice subjects in Barbados Ethn. Dis., 14 (2004),pp. 57-63
[37]	Rosa, A., Brehem, A. African human mtDNA phylogeography at-a-glance J. Anthropol. Sci., 89 (2011),pp. 25-58
[38]	Salas, A., Richards, M., De La Fe, T. et al. The making of the African mtDNA landscape Am. J. Hum. Genet., 71 (2002),pp. 1082-1111
[39]	Salas, A., Elson, J.L. Mitochondrial DNA as a risk factor for false positives in case-control association studies J. Genet. Genomics, 42 (2015),pp. 169-172
[40]	Samuels, D.C., Carothers, A.D., Horton, R. et al. The power to detect disease associated with mitochondrial DNA haplogroups Am. J. Hum. Genet., 78 (2006),pp. 713-720
[41]	Schutte, A.E., Schutte, R., Huisman, H.W. et al. Are behavioural risk factors to be blamed for the conversion from optimal blood pressure to hypertensive status in Black South Africans? A 5-year prospective study Int. J. Epidemiol., 14 (2012),pp. 1114-1123
[42]	Soares, P., Abrantes, D., Rito, T. et al. Evaluating purifying selection in the mitochondrial DNA of various mammalian species PLoS One, 8 (2013),p. e58993
[43]	Taylor, R.W., Giordano, C., Davidson, M.M. et al. A homoplasmic mitochondrial transfer ribonucleic acid mutation as a cause of maternally inherited hypertrophic cardiomyopathy J. Am. Coll. Cardiol., 41 (2003),pp. 1786-1796
[44]	Thusberg, J., Olatubosun, A., Vihinen, M. Performance of mutation pathogenicity prediction methods on missense variants Hum. Mutat., 32 (2011),pp. 358-368
[45]	Tuppen, H.A., Blakely, E.L., Turnbull, D.M. et al. Mitochondrial DNA mutations and human disease Biochim. Biophys. Acta, 1797 (2010),pp. 113-128
[46]	van der Walt, E.M., Smuts, I., Taylor, R.W. et al. Characterization of mtDNA variation in a cohort of South African paediatric patients with mitochondrial disease J. Hum. Genet., 20 (2012),pp. 650-656
[47]	van der Westhuizen, F.H., Sinxadi, P.Z., Dandara, C. et al. Understanding the implications of mitochondrial DNA variation in the health of Black Southern African populations: the 2014 Workshop Hum. Mutat., 36 (2015),pp. 569-571
[48]	van Oven, M., Kayser, M. Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation Hum. Mutat., 30 (2009),pp. E386-E394
[49]	Wallace, D. Bioenergetics and the epigenome: interface between the environment and genes in common diseases Dev. Disabil. Res. Rev., 16 (2010),pp. 114-116
[50]	Weissensteiner, H., Pacher, D., Kloss-Brandstätter, A. et al. HaploGrep 2: mitochondrial haplogroup classification in the era of high-throughput sequencing Nucleic Acids Res., 44 (2016),pp. W58-W63
[51]	World Medical Association World Medical Association declaration of Helsinki: ethical principles for medical research involving human subjects J. Int. Bioethique, 1 (2004),p. 124
[52]	Yarham, J.W., Elson, J.L., Blakely, E.L. et al. Mitochondrial tRNA mutations and disease Wiley Interdiscip. Rev. RNA, 1 (2010),pp. 304-324
[53]	Yu, X., Koczan, D., Sulonen, A.-M. et al. mtDNA nt13708A variant increases the risk of multiple sclerosis PLoS One, 3 (2008),p. e153